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1. Introduction 
5-Aza-2’deoxycytidine has preferential affinity for 
the lymphatic system [ 1,2] and displays pronounced 
growth-inhibitory action against various forms of 
experimental neoplasias [3,4] . Although 20-times 
less active in Escherichia coli B than 5-azacytidine the 
deoxy-aza analogue exhibits still remarkable anti- 
bacterial effects which can be completely removed 
by natural pyrimidine precursors [5] . 
The 5azapyrimidine deoxyribonucleoside is an 
efficient donor of the deoxyribosyl group promoting 
in E. coli the deoxyriboside-dependent incorporation 
of thymine [6]. However, the deamination to 5-aza- 
2’deoxyuridine seems to be necessary for the utiliza- 
tion of the deoxyribose moiety of 5-aza-2’-deoxy- 
cytidine since its uptake was lost in bacterial mutants 
deficient in cytidine deaminase [7] where 5-aza-2’- 
deoxycytidine had practically no inhibitory effect. It 
was proposed that the analogue enters the cells of 
E. coli via deamination followed by the phosphoro- 
lytic cleavage of the glycosidic bond [7] . 
The deamination of 5-aza-2’deoxycytidine takes 
place also in mice and results in the formation of 
5-azauracil which has been isolated from the urine 
of drug-treated animals [2]. Recently the phosphoryl- 
ation of 5-aza-2’-deoxycytidine to higher 5’-phosphates 
in parallel with the incorporation of the fraudulent 
deoxyribonucleotide into DNA was described in 
different systems of eukaryotic cells [4,8] . The aim 
of the present study was to follow the metabolic 
conversion and incorporation of 5-aza-2’-deoxycyti- 
dine in E. coli using tritium-labelled drug of high 
specific radioactivity. 
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2. Materials and methods 
Cultivation of E. coli B was performed at 37’C by 
the stationary method in a synthetic medium con- 
taining glucose [93 . Inoculation was carried out with 
a 15 h E. coli culture added in an amount of 2% of 
the total volume. 5-Azauracil and 5-aza-2’deoxy- 
cytidine were prepared in the Department of Organic 
Synthesis of this Institute. Tetrahydrouridine was a 
gift from Dr G. L. Neil, The Upjohn Company, 
Kalamazoo. 
The incorporation of 5-aza-2’-[3H]deoxycytidine 
(19.5 Ci/mmol) which was prepared by Dr B. tern9 
from the Isotope Laboratory, Prague-K& was followed 
as described in the legend to fig.1. 5-Aza-[3H]uracil 
was prepared from 5-aza-2’-[3H]deoxycytidine using 
the cell-free extract of E. coli as is shown in tig.3. 
Description of individual experiments is presented in 
the legends to figures. The radioactivity on chromato- 
grams was detected using automatic Frieseke-Hoepfner 
scanner and the radioactivity of samples was measured 
using liquid scintillation system Isocap/300 (Nuclear 
Chicago Division). 
3. Results 
5-Aza-2’deoxycytidine inhibits the growth of 
E. coli B in a mineral medium supplemented with 
glucose at the concentration of 1 ~g/millilitre by 50% 
[5] .5-Azauracil displays similar inhibitory effect 
while 5-azacytosine is about lOOO-times less active. 
Consequently, we followed incorporation of the 
labelled 5-aza-2’deoxycytidine and 5-azauracil into 
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Fig.1. Incorporation of S-aza-2’-[ “Hldeoxycytidine and 
5-aza-[ ‘Hluracil in E. coli. Washed bacterial cells collected 
in the logarithmic phase of culture growth were suspended 
in a mineral medium supplemented with glucose and incu- 
bated in total vol. 3 ml in the presence of 0.15 pmol 
S-aza-2’-[ ‘Hldeoxycytidine (800 &i) or S-aza-[sH]uracil 
(100 MCi). At different time intervals (min) 0.5 ml portions 
of the incubation mixture were analyzed [ 21 for the 
uptake of the label into the acid-insoluble fraction of nucleic 
acids (dpm/fraction). 
the fraction of nucleic acids in E. coli. The data 
presented in fig.1 show that the two azapyrimidines 
are incorporated into nucleic acids but to a different 
degree. 5-Aza-2’-[3H]deoxycytidine is utilized about 
IO-times more effectively than 5-aza-[3H]uracil. 
Using 25-times higher concentration of 5-aza-[2,4-14C] 
uracilO.4-0.7% of the drug was present in the acid- 
soluble pool of E. coli cultivated 16 h with the 
analogue in the form of ribosylated compounds [IO] . 
Analysis of the acid soluble pool of E. coli incu- 
bated 30 min in the presence of 5-aza-2’-[3H]deoxy- 
cytidine revealed a significant level of 5-aza-[3H]uracil, 
unchanged deoxy analogue and respective degradation 
products With the highest RF-values (fig.2). It seems 
that 5-aza-[3H]uracil formed from 5-aza-2’-[3H]deoxy- 
cytidine during the uptake of the fraudulent deoxy- 
nucleoside into bacterial cells is incorporated into 
nucleic acids more efficiently than 5-aza-[‘Hluracil 
added to baterial suspension. However, part of the 
radioactivity of tritium-labelled 5-aza-2’deoxycytidine 
might be incorporated into nucleic acids also by other 
mechanisms which are mentioned below. 
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Fig.2. Radioactive compounds in the acid-soluble pool of 
E. coli cultivated in the presence of 5-aza-2’-[“Hldeoxycyti- 
dine. The cells incubated as in fig.1 were extracted under 
cooling with equal vol. 0.4 M HClO,. The extract was neutra- 
lized by 2 M KOH, centrifuged and supernatant separated 
chromatographically on Whatman No. 3 paper using solvent 
system composed of isobutyric acid/ammonium hydroxide/ 
water (44:1:22). (1) 5-Azauracil; (2), S-aza-2’deoxycytidine. 
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Fig.3. Inhibitory effect of tetrahydrouridine on metabolic 
conversion of 5-aza-2’-[ ‘H] deoxycytidine in the cell-free 
extract of E. coli. Bacteria harvested in the logarithmic phase 
of culture growth were suspended in 40 mM Tris-HCl 
buffer (pH 7.5), desintegrated (MSE ultrasonic desintegrator, 
1 min, 2°C) and the fraction centrifuged (10 000 X g, 30 min, 
2°C). Aliquots of the supernatant enzyme fractions were 
incubated 15 min at 37’C in total vol. 0.3 ml in the presence 
of 1 mM MgCl, and 0.05 mM S-sza-2’j”Hldeoxycytidine 
with increasing concentrations of tetmhydrouridine (mM). 
The separation of unreacted S-aza-2’deoxycytidine and of 
the newly formed 5-azauracil was carried out chromato- 
graphically on Whatman No. 1 paper as in fig.2. The corre- 
sponding spots were cut out and their radioactivity was 
measured (cpm). 
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resulting in ?he formation of Sazauracil takes place 
also in the cell-free extract of E. colz’ (fig.3). Tetra- 
hydrouridine affecting the deamination of cytosine 
arabinoside [ 1 l] inhibits also the deamination of 
S-aza-2’-deoxycytidine as revealed by the lower level 
of the newly formed Cazauracil. However, the inter- 
mediate component, Saza-2’-deoxyuridine, was not 
detected in the incubation mixture. 
4. Discussion 
5-Aza-2’deoxycytidine is deaminated and under- 
goes nucleosidic leavage resulting in the formation 
of 5azauracil that was detected in vivo in the acid 
soluble pool of the drug-treated cells as well as in 
vitro using the cell-free extract of E.coZi (figs 2 and 3). 
While 5azauracil and 5-aza-2’deoxycytidine have 
practically the same inhibitory efficiency in E. coli 
[2] both compounds are taken up into cellular nucleic 
acids to a different degree. It is supposed that the 
lower uptake of 5-aza[3H]uracil (fig.1) reflects the 
incorporation of the drug into RNA since it reacts 
with 5-phosphoribosyl-l-pyrophosphate giving rise 
to 5azauridine 5’-monophosphate [9] . 
On the other hand, the uptake of the label from 
5-aza-2’-[3H]deoxycytidine is likely to go both into 
RNA (through the formation of 5-azauracil) and 
DNA. 5-Aza-2’-deoxycytidine as an efficient donor 
of the deoxyribose supports the incorporation of 
thymine into DNA [6,7] . Moreover, the analogue 
itself can be incorporated into DNA. DNA with the 
labelled drug was recently isolated from the liver of 
leukemic mice injected with 5-aza-2’-[3H]deoxycyti- 
dine [4]. However, since in E. cob the rate of deami- 
nation of the analogue deoxynucleoside is much 
higher than in eukaryotic systems only limited uptake 
of intact 5-aza-2’-deoxycytidine to bacterial DNA 
can be expected. 
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